RAC 2.92% $1.94 race oncology ltd

If RAC were going to market Zantrene by themselves they should...

  1. 2,920 Posts.
    lightbulb Created with Sketch. 1297
    If RAC were going to market Zantrene by themselves they should already be half way through the Paeds AML trial for the PRV. They've had enough cash for that for ages. That would be extremely handy!

    IMO.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.